PEN:NYSE
Penumbra Inc
US$ ३१७.५५
arrow_downward
-०.१४%(-०.४५) 1D
US$ ३१७.५४
arrow_downward
-०.००% (-०.००७९)bedtimeAfter hours
Closed: अक्टोबर २, १६:००:०४ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
US$ ३१८.३७
High
US$ ३१८.३७
Low
US$ ३१६.७८
Mkt. cap
१२.५१ अरब
Avg. vol.
३.५२ लाख
Volume
२.४० लाख
P/E ratio
७७.९९
52-wk high
US$ ३६२.४१
52-wk low
US$ २२१.२६
EPS
US$ ४.०७
Beta
०.७०
Shares outstanding
३.९४ करोड
No. of employees
५ हजार
Open
US$ ३१८.३७
High
US$ ३१८.३७
Low
US$ ३१६.७८
Mkt. cap
१२.५१ अरब
Avg. vol.
३.५२ लाख
Volume
२.४० लाख
P/E ratio
७७.९९
52-wk high
US$ ३६२.४१
52-wk low
US$ २२१.२६
EPS
US$ ४.०७
Beta
०.७०
Shares outstanding
३.९४ करोड
No. of employees
५ हजार
News stories
From web sources and news partners
Proactive financial news
·
२१ मिनेट पहिले
Nova Minerals to host investor webinar on Estelle and US antimony strategy
Simply Wall Street
·
२७ मिनेट पहिले
EasySource Marketplace Listing Might Change The Case For Investing In Paylocity (PCTY)
FXLeaders
·
१ घण्टा पहिले
Dow Jones and Nasdaq Futures Open Higher as Buyers Target New Records
USA Today
·
१३ घण्टा पहिले
Is a stock market correction coming? Most Americans think so
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc